Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028636 · ClinicalTrials.gov registry record
LIBERATE - PRO: Eclipse™ System Registry
A clinical trial, sponsored by Pelvalon.
- Completed
- Registry status
- 17
- Enrollment target
NCT03028636 is a clinical trial that has completed, run by Pelvalon. The registered enrollment target is 17 participants.
The verdict
NCT03028636 has completed, sponsored by Pelvalon.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
A prospective, open label post market registry to collect Patient Reported Outcomes in an online data capture registry, maintained by Pelvalon, of women with fecal incontinence exiting the LIBERATE study (NCT02428595) continuing to use the Eclipse System for bowel control.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-09-19 |
| Est. Completion | 2019-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028636
The ClinicalTrials.gov registry entry for NCT03028636 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pelvalon, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03028636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03028636 about?
NCT03028636 is a clinical study titled "LIBERATE - PRO: Eclipse™ System Registry". A prospective, open label post market registry to collect Patient Reported Outcomes in an online data capture registry, maintained by Pelvalon, of women with fecal incontinence exiting the LIBERATE study (NCT02428595) continuing to use the Eclipse System for bowel control.
What is the current status of trial NCT03028636?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2016-09-19. Estimated completion is 2019-02-27.
Who is sponsoring clinical trial NCT03028636?
This trial is sponsored by Pelvalon, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.